- Home
- KRKR vs ADIL Comparison
KRKR vs ADIL Comparison
Compare KRKR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRKR | ADIL |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 7.8M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | KRKR | ADIL |
|---|---|---|
| Price | $4.08 | $0.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 2.8K | ★ 360.6K |
| Earning Date | 09-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,966,526.00 | N/A |
| Revenue This Year | $182.55 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $0.22 |
| 52 Week High | $21.36 | $1.30 |
Technical Indicators
Market Signals| Indicator | KRKR | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 29.13 |
| Support Level | $4.13 | $0.30 |
| Resistance Level | $4.65 | $0.29 |
| Average True Range (ATR) | 0.32 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 19.17 | 2.56 |
Price Performance
Historical ComparisonAbout KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.